Lantus and Efudex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lantus (insulin glargine recombinant) and Efudex (fluorouracil). Common drug interactions include hiatus hernia among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Lantus and Efudex. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

What is Efudex?

Efudex has active ingredients of fluorouracil. It is often used in actinic keratosis. eHealthMe is studying from 1,391 Efudex users. Check the latest studies of Efudex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

11 people who take Lantus and Efudex together, and have interactions are studied.

Lantus and Efudex drug interactions.

What are the common drug interactions of Lantus and Efudex, by gender? *:

female:

  1. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  2. Hyperglycaemia (high blood sugar)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Hypersensitivity
  5. Hypopnoea (decrease in the breathing rate)
  6. Impaired healing
  7. Injury
  8. Insomnia (sleeplessness)
  9. Lentigo (a small pigmented spot on the skin with a clearly-defined edge, surrounded by normal-appearing skin)
  10. Lip ulceration (ulcer of lip)

male:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Essential hypertension (primary hypertension)
  4. Gout (uric acid crystals building up in the body)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Herpes simplex (herpes simplex is a common viral infection)
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Lantus and Efudex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Hepatic mass
  2. Hepatic steatosis (fatty liver disease)
  3. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  4. Hyperglycaemia (high blood sugar)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Hypersensitivity
  7. Hypopnoea (decrease in the breathing rate)
  8. Impaired healing
  9. Injury
  10. Insomnia (sleeplessness)

60+:

  1. Abdominal discomfort
  2. Abdominal pain
  3. Essential hypertension (primary hypertension)
  4. Gout (uric acid crystals building up in the body)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Herpes simplex (herpes simplex is a common viral infection)
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Hypercholesterolaemia (high levels of cholesterol in the blood)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Breast Cancer Female: 5 people, 45.45%
  2. Pain: 4 people, 36.36%
  3. High Blood Pressure: 3 people, 27.27%
  4. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 18.18%
  5. Asthma: 2 people, 18.18%
  6. Prostate Cancer: 2 people, 18.18%
  7. Constipation: 2 people, 18.18%
  8. Depression: 2 people, 18.18%
  9. Indigestion: 2 people, 18.18%
  10. Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Lantus and Efudex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lantus and Efudex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lantus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Efudex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lantus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Efudex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine recombinant and fluorouracil (the active ingredients of Lantus and Efudex, respectively), and Lantus and Efudex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: